Health
FDA Approves Monthly Injectable HIV Drug Combo – Star Observer
The United States Food and Drug Administration on Thursday approved Cabenuva, for the treatment of HIV in adults.
The United States Food and Drug Administration on Thursday approved Cabenuva, a once a month injectable drug combination with cabotegravir and rilpivirine, for the treatment of HIV in adults.
Currently, the standard of care for patients with HIV includes patients taking daily pills to adequately manage their condition. This approval will allow some patients the option of receiving once-monthly injections in lieu of a daily oral treatment regimen, said Dr. John Farley, director of the Office of…
-
Business16 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General24 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business15 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
Business19 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM